IT1194844B - Soluzione di amminoacidi per pazienti affetti da carcinoma - Google Patents

Soluzione di amminoacidi per pazienti affetti da carcinoma

Info

Publication number
IT1194844B
IT1194844B IT05216/79A IT521679A IT1194844B IT 1194844 B IT1194844 B IT 1194844B IT 05216/79 A IT05216/79 A IT 05216/79A IT 521679 A IT521679 A IT 521679A IT 1194844 B IT1194844 B IT 1194844B
Authority
IT
Italy
Prior art keywords
carcinoma
patients
amino acid
acid solution
solution
Prior art date
Application number
IT05216/79A
Other languages
English (en)
Italian (it)
Other versions
IT7905216A0 (it
Inventor
Ozeki Koji
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of IT7905216A0 publication Critical patent/IT7905216A0/it
Application granted granted Critical
Publication of IT1194844B publication Critical patent/IT1194844B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
IT05216/79A 1978-09-04 1979-09-03 Soluzione di amminoacidi per pazienti affetti da carcinoma IT1194844B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
IT7905216A0 IT7905216A0 (it) 1979-09-03
IT1194844B true IT1194844B (it) 1988-09-28

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
IT05216/79A IT1194844B (it) 1978-09-04 1979-09-03 Soluzione di amminoacidi per pazienti affetti da carcinoma

Country Status (10)

Country Link
JP (1) JPS5535049A (de)
AU (1) AU526207B2 (de)
CA (1) CA1134275A (de)
CH (1) CH642541A5 (de)
DE (1) DE2935709C2 (de)
FR (1) FR2434622A1 (de)
GB (1) GB2029220B (de)
IT (1) IT1194844B (de)
NL (1) NL190266C (de)
SE (1) SE448679B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0076841A4 (de) * 1981-04-17 1984-01-16 American Hospital Supply Corp Verbesserte lösung für parenterale nährung.
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
EP0560989B1 (de) * 1991-10-07 1999-09-01 Otsuka Pharmaceutical Factory, Inc. Enterale zubereitungen zur krebstherapie
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
DK0668933T3 (da) * 1992-11-19 2003-02-10 Anticancer Inc Anvendelse af methioninase som antitumormiddel i antimethioninkemoterapi
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
EP0921794A1 (de) * 1996-07-30 1999-06-16 Novartis Nutrition AG Aminosäure enthaltende zusammensetzung und dessen verwendung zur behandlung von tumorwachstum und metastasen
EP1068868A3 (de) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistischer Zusammensetzung, der Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeneration
PT1163904E (pt) * 2000-06-16 2006-07-31 Rath Matthias Composicao para a prevencao de doencas do musculo liso, compreendendo ascorbato, arginina e magnesio
DE60028376T2 (de) * 2000-10-09 2007-06-06 Rath, Matthias, Dr. Therapeutische Kombination des Ascorbats mit Lysin und Arginin für Verhinderung und Behandlung des Krebses
CH694549A5 (de) 2001-01-16 2005-03-31 Dr Matthias Rath Verwendung einer synergistischen Zusammensetzung, die Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeration.
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
JPWO2003030890A1 (ja) * 2001-10-05 2005-02-10 哲朗 浅尾 免疫系活性化剤
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
EP1734819A1 (de) * 2004-03-19 2006-12-27 Pro-Pharmaceuticals, Inc. Zusammensetzungen und verfahren für das targeting von metastasierenden tumoren mit hilfe von mehrwertigen ligandgebundenen kohlenhydratpolymeren
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
US8580750B2 (en) * 2005-07-29 2013-11-12 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
EP2156188B1 (de) 2007-03-28 2021-05-05 University of Southern California Induktion differentieller stressresistenz und verwendungen davon
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
CA3045883C (en) * 2008-04-24 2022-06-28 University Of Southern California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
EP2676664B1 (de) * 2011-02-17 2017-06-21 EA Pharma Co., Ltd. Verstärker der antitumorwirkung eines chemotherapeutischen mittels
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compounds for the treatment of liver disease
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (de) * 1968-05-09 1972-04-10 Astra Ab Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
SU423304A3 (de) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (de) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Mittel zur Behandlung und Verhütung von Leberkrankheiten und muskulärer Insuffizienz
DE2530246A1 (de) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531204A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung

Also Published As

Publication number Publication date
SE7907316L (sv) 1980-03-05
JPS6154007B2 (de) 1986-11-20
FR2434622B1 (de) 1983-04-15
NL190266B (nl) 1993-08-02
AU526207B2 (en) 1982-12-23
GB2029220A (en) 1980-03-19
AU5036879A (en) 1980-03-13
NL190266C (nl) 1994-01-03
FR2434622A1 (fr) 1980-03-28
CH642541A5 (de) 1984-04-30
NL7906620A (nl) 1980-03-06
GB2029220B (en) 1983-03-30
CA1134275A (en) 1982-10-26
SE448679B (sv) 1987-03-16
JPS5535049A (en) 1980-03-11
DE2935709A1 (de) 1980-03-13
IT7905216A0 (it) 1979-09-03
DE2935709C2 (de) 1986-02-06

Similar Documents

Publication Publication Date Title
IT1194844B (it) Soluzione di amminoacidi per pazienti affetti da carcinoma
NO149531C (no) Administreringssett
DK579875A (da) Aminosyrepreparater
DK136579A (da) Thioetiansyrederivater
DK468379A (da) Praeparater med langvarig medikamentafgivelse
DK411879A (da) Koblingsorgan for plasticroer
DK198179A (da) Dialyseoploesning
KR840004668A (ko) 5-펜타노익산류
DK348079A (da) Administrationsform
NO153205C (no) Tannrensemiddel.
FI791456A (fi) Farmaceutiska foereningar
LU88308I2 (fr) Remoxipride (Roxiam)
FI56873B (fi) Med formkuggar foersedd valskonstruktion foer avfallskrossanordning avsedd foer avstjaelpningsplatser
DK219779A (da) Anti-caries praeparater
SE8004166L (sv) Cykliska iminokarboxylsyraderivat
JPS54157817A (en) Pharmaceutical prepared solution
DK384379A (da) Etmidatholdige praeparater
BE840227A (fr) Solution parenterale d'amino-acides
IT1164927B (it) Catodo per elettrolizzatori
DK148196C (da) Doseringsanlaeg
FR2314732A1 (fr) Solution d'iodophore
DK136378A (da) Doseringspumpe
SE7811562L (sv) Forfaringssett for omroring
IT1096213B (it) Procedimento di clorurazione di alfa-amminoacidi
IT1122311B (it) Procedimento per la preparazione di triciclazolo